144 related articles for article (PubMed ID: 25929297)
1. Serum fibroblast growth factor 21 in overweight and obese Thai children and adolescents: its relation to glucose metabolism and its change after glucose loading.
Korwutthikulrangsri M; Mahachoklertwattana P; Chanprasertyothin S; Pongratanakul S; Poomthavorn P
Clin Endocrinol (Oxf); 2015 Dec; 83(6):820-7. PubMed ID: 25929297
[TBL] [Abstract][Full Text] [Related]
2. Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation.
Strączkowski M; Karczewska-Kupczewska M; Adamska A; Otziomek E; Kowalska I; Nikołajuk A
Int J Obes (Lond); 2013 Oct; 37(10):1386-90. PubMed ID: 23419601
[TBL] [Abstract][Full Text] [Related]
3. Dynamic change of serum FGF21 levels in response to glucose challenge in human.
Lin Z; Gong Q; Wu C; Yu J; Lu T; Pan X; Lin S; Li X
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1224-8. PubMed ID: 22539584
[TBL] [Abstract][Full Text] [Related]
4. Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.
Li H; Bao Y; Xu A; Pan X; Lu J; Wu H; Lu H; Xiang K; Jia W
J Clin Endocrinol Metab; 2009 Jun; 94(6):2151-6. PubMed ID: 19318452
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and impaired glucose tolerance in overweight and obese Costa Rican schoolchildren.
Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
Food Nutr Bull; 2008 Jun; 29(2):123-31. PubMed ID: 18693476
[TBL] [Abstract][Full Text] [Related]
6. Postprandial changes in glucose oxidation and insulin sensitivity in metabolic syndrome: Influence of fibroblast growth factor 21 and vitamin D status.
Pathak K; Soares MJ; Zhao Y; James AP; Sherriff JL; Newsholme P
Nutrition; 2017 May; 37():37-42. PubMed ID: 28359360
[TBL] [Abstract][Full Text] [Related]
7. Relationship of serum fibroblast growth factor 21 with abnormal glucose metabolism and insulin resistance: the Baltimore Longitudinal Study of Aging.
Semba RD; Sun K; Egan JM; Crasto C; Carlson OD; Ferrucci L
J Clin Endocrinol Metab; 2012 Apr; 97(4):1375-82. PubMed ID: 22344195
[TBL] [Abstract][Full Text] [Related]
8. Glucose tolerance status in 510 children and adolescents attending an obesity clinic in Central Italy.
Brufani C; Ciampalini P; Grossi A; Fiori R; Fintini D; Tozzi A; Cappa M; Barbetti F
Pediatr Diabetes; 2010 Feb; 11(1):47-54. PubMed ID: 19460122
[TBL] [Abstract][Full Text] [Related]
9. Serum glypican 4 level in obese children and its relation to degree of obesity.
Leelalertlauw C; Korwutthikulrangsri M; Mahachoklertwattana P; Chanprasertyothin S; Khlairit P; Pongratanakul S; Poomthavorn P
Clin Endocrinol (Oxf); 2017 Dec; 87(6):689-695. PubMed ID: 28746787
[TBL] [Abstract][Full Text] [Related]
10. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
Cambuli VM; Incani M; Pilia S; Congiu T; Cavallo MG; Cossu E; Sentinelli F; Mariotti S; Loche S; Baroni MG
Diabetes Metab Res Rev; 2009 Sep; 25(6):528-34. PubMed ID: 19496065
[TBL] [Abstract][Full Text] [Related]
11. Circulating FGF21 levels are related to nutritional status and metabolic but not hormonal disturbances in polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Madej P; Wdowczyk M; Owczarek A; Chudek J
Eur J Endocrinol; 2015 Feb; 172(2):173-9. PubMed ID: 25411238
[TBL] [Abstract][Full Text] [Related]
12. Adipose Insulin Resistance in Obese Adolescents Across the Spectrum of Glucose Tolerance.
Hershkop K; Besor O; Santoro N; Pierpont B; Caprio S; Weiss R
J Clin Endocrinol Metab; 2016 Jun; 101(6):2423-31. PubMed ID: 27054297
[TBL] [Abstract][Full Text] [Related]
13. Effects of Interrupting Sedentary Behavior With Short Bouts of Moderate Physical Activity on Glucose Tolerance in Children With Overweight and Obesity: A Randomized Crossover Trial.
Broadney MM; Belcher BR; Berrigan DA; Brychta RJ; Tigner IL; Shareef F; Papachristopoulou A; Hattenbach JD; Davis EK; Brady SM; Bernstein SB; Courville AB; Drinkard BE; Smith KP; Rosing DR; Wolters PL; Chen KY; Yanovski JA
Diabetes Care; 2018 Oct; 41(10):2220-2228. PubMed ID: 30082324
[TBL] [Abstract][Full Text] [Related]
14. Serum FGF21 in girls with anorexia nervosa - comparison to normal weight and obese female adolescents.
Mikolajczak A; Oswiecimska JM; Swietochowska E; Roczniak W; Ziora KT
Neuro Endocrinol Lett; 2017 Jul; 38(3):173-181. PubMed ID: 28759185
[TBL] [Abstract][Full Text] [Related]
15. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
[TBL] [Abstract][Full Text] [Related]
16. The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans.
Ter Horst KW; Gilijamse PW; Demirkiran A; van Wagensveld BA; Ackermans MT; Verheij J; Romijn JA; Nieuwdorp M; Maratos-Flier E; Herman MA; Serlie MJ
Mol Metab; 2017 Nov; 6(11):1493-1502. PubMed ID: 29107295
[TBL] [Abstract][Full Text] [Related]
17. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
Iglesias P; Selgas R; Romero S; Díez JJ
Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
[TBL] [Abstract][Full Text] [Related]
18. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.
Cuevas-Ramos D; Almeda-Valdes P; Gómez-Pérez FJ; Meza-Arana CE; Cruz-Bautista I; Arellano-Campos O; Navarrete-López M; Aguilar-Salinas CA
Eur J Endocrinol; 2010 Sep; 163(3):469-77. PubMed ID: 20566587
[TBL] [Abstract][Full Text] [Related]
19. Proinsulin and the proinsulin/insulin ratio in overweight and obese children and adolescents: relation to clinical parameters, insulin resistance, and impaired glucose regulation.
von Berghes C; Brabant G; Biebermann H; Krude H; Wiegand S
Pediatr Diabetes; 2011 May; 12(3 Pt 2):242-9. PubMed ID: 21518412
[TBL] [Abstract][Full Text] [Related]
20. Increased glucose-stimulated FGF21 response to oral glucose in obese nondiabetic subjects after Roux-en-Y gastric bypass.
Vienberg SG; Jacobsen SH; Worm D; Hvolris LE; Naver L; Almdal T; Hansen DL; Wulff BS; Clausen TR; Madsbad S; Holst JJ; Andersen B
Clin Endocrinol (Oxf); 2017 Jan; 86(1):156-159. PubMed ID: 27649688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
